AAAAAA

   
Results: 1-17 |
Results: 17
THE MANAGEMENT OF STAGE-I TESTIS CANCER
Authors: STERNBERG CN
Citation: Cn. Sternberg, THE MANAGEMENT OF STAGE-I TESTIS CANCER, Urologic clinics of North America, 25(3), 1998, pp. 435
RESULTS OF A EUROPEAN MULTICENTER TRIAL COMPARING THE BTA TRAK TEST TO URINE CYTOLOGY IN PATIENTS SUSPECTED OF HAVING BLADDER-CANCER
Authors: LEYH H TREIBER U THOMAS L MARBERGER M STERNBERG CN PANSADORO V PAGANO F BASSI P BOMBARDIERI E CONORT P BOCCONGIBOD L RAVERY V LEGULUDEC D ISHAK L
Citation: H. Leyh et al., RESULTS OF A EUROPEAN MULTICENTER TRIAL COMPARING THE BTA TRAK TEST TO URINE CYTOLOGY IN PATIENTS SUSPECTED OF HAVING BLADDER-CANCER, The Journal of urology, 159(5), 1998, pp. 934-934
LOBAPLATIN IN ADVANCED UROTHELIAL TRACT TUMORS
Authors: STERNBERG CN DEMULDER P FOSSA S KAYE S ROBERTS T PAWINSKY A DAAMEN S
Citation: Cn. Sternberg et al., LOBAPLATIN IN ADVANCED UROTHELIAL TRACT TUMORS, Annals of oncology, 8(7), 1997, pp. 695-696
RESULTS OF BARD BTA TEST IN MONITORING PATIENTS WITH A HISTORY OF TRANSITIONAL-CELL CANCER OF THE BLADDER
Authors: IANARI A STERNBERG CN ROSSETTI A VANRIJN A DEIDDA A GIANNARELLI D PANSADORO V
Citation: A. Ianari et al., RESULTS OF BARD BTA TEST IN MONITORING PATIENTS WITH A HISTORY OF TRANSITIONAL-CELL CANCER OF THE BLADDER, Urology, 49(5), 1997, pp. 786-789
PRELIMINARY-RESULTS OF A EUROPEAN MULTICENTER CLINICAL-TRIAL COMPARING THE BARD(R) BTA TRAK(TM) TEST TO URINE CYTOLOGY IN PATIENTS SUSPECTED OF HAVING BLADDER-CANCER
Authors: ISHAK L THOMAS L LEYH H MARBERGER M BOMBARDIERI E BASSI P PAGANO F PANSADORO V STERNBERG CN BOCCONGIBOD L CONORT P LEGULUDEC D
Citation: L. Ishak et al., PRELIMINARY-RESULTS OF A EUROPEAN MULTICENTER CLINICAL-TRIAL COMPARING THE BARD(R) BTA TRAK(TM) TEST TO URINE CYTOLOGY IN PATIENTS SUSPECTED OF HAVING BLADDER-CANCER, Clinical chemistry, 43, 1997, pp. 579-579
NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED BLADDER-CANCER
Authors: STERNBERG CN
Citation: Cn. Sternberg, NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN LOCALLY ADVANCED BLADDER-CANCER, Seminars in oncology, 23(5), 1996, pp. 621-632
THE TREATMENT OF ADVANCED BLADDER-CANCER
Authors: STERNBERG CN
Citation: Cn. Sternberg, THE TREATMENT OF ADVANCED BLADDER-CANCER, Annals of oncology, 6(2), 1995, pp. 113-126
BLADDER PRESERVATION - A PROSPECT FOR PATIENTS WITH URINARY-BLADDER CANCER
Authors: STERNBERG CN
Citation: Cn. Sternberg, BLADDER PRESERVATION - A PROSPECT FOR PATIENTS WITH URINARY-BLADDER CANCER, Acta oncologica, 34(5), 1995, pp. 589-597
PROGNOSTIC IMPACT OF TRANSURETHRAL RESECTION ON PATIENTS IRRADIATED FOR LOCALIZED PROSTATE-CANCER
Authors: ARCANGELI G MICHELI A VERNA L SARACINO B ARCANGELI G GIOVINAZZO G DANGELO L PANSADORO V STERNBERG CN
Citation: G. Arcangeli et al., PROGNOSTIC IMPACT OF TRANSURETHRAL RESECTION ON PATIENTS IRRADIATED FOR LOCALIZED PROSTATE-CANCER, Radiotherapy and oncology, 35(2), 1995, pp. 123-128
BACILLUS-CALMETTE-GUERIN IN THE TREATMENT OF STAGE T1 GRADE-3 TRANSITIONAL-CELL CARCINOMA OF THE BLADDER - LONG-TERM RESULTS
Authors: PANSADORO V EMILIOZZI P DEFIDIO L DONADIO D FLORIO A MAURELLI S LAURETTI S STERNBERG CN
Citation: V. Pansadoro et al., BACILLUS-CALMETTE-GUERIN IN THE TREATMENT OF STAGE T1 GRADE-3 TRANSITIONAL-CELL CARCINOMA OF THE BLADDER - LONG-TERM RESULTS, The Journal of urology, 154(6), 1995, pp. 2054-2058
THE APPLICATION OF HEMATOPOIETIC GROWTH-FACTORS IN ADVANCED TRANSITIONAL-CELL CARCINOMA OF THE URINARY-TRACT
Authors: DEMULDER PHM STERNBERG CN VANOOSTEROM AT FOSSA SD
Citation: Phm. Demulder et al., THE APPLICATION OF HEMATOPOIETIC GROWTH-FACTORS IN ADVANCED TRANSITIONAL-CELL CARCINOMA OF THE URINARY-TRACT, Seminars in oncology, 21(1), 1994, pp. 65-69
DOCETAXEL (TAXOTERE(TM)), A NOVEL TAXOID, IN THE TREATMENT OF ADVANCED COLORECTAL-CARCINOMA - AN EORTC EARLY CLINICAL-TRIALS GROUP-STUDY
Authors: STERNBERG CN HUININK WWTB SMYTH JF BRUNTSCH V DIRIX LY PAVLIDIS NA FRANKLIN H WANDERS S LEBAIL N KAYE SB
Citation: Cn. Sternberg et al., DOCETAXEL (TAXOTERE(TM)), A NOVEL TAXOID, IN THE TREATMENT OF ADVANCED COLORECTAL-CARCINOMA - AN EORTC EARLY CLINICAL-TRIALS GROUP-STUDY, British Journal of Cancer, 70(2), 1994, pp. 376-379
ESCALATED M-VAC CHEMOTHERAPY AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN PATIENTS WITH ADVANCED UROTHELIAL TRACT TUMORS
Authors: STERNBERG CN DEMULDER PHM VANOOSTEROM AT FOSSA SD GIANNARELLI D SOEDIRMAN JR
Citation: Cn. Sternberg et al., ESCALATED M-VAC CHEMOTHERAPY AND RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF) IN PATIENTS WITH ADVANCED UROTHELIAL TRACT TUMORS, Annals of oncology, 4(5), 1993, pp. 403-407
ADJUVANT CHEMOTHERAPY FOLLOWING RADICAL CYSTECTOMY
Authors: STERNBERG CN
Citation: Cn. Sternberg, ADJUVANT CHEMOTHERAPY FOLLOWING RADICAL CYSTECTOMY, World journal of urology, 11(3), 1993, pp. 169-174
ROLE OF PRIMARY CHEMOTHERAPY IN STAGE I AND LOW-VOLUME STAGE-II NONSEMINOMATOUS GERM-CELL TESTIS TUMORS
Authors: STERNBERG CN
Citation: Cn. Sternberg, ROLE OF PRIMARY CHEMOTHERAPY IN STAGE I AND LOW-VOLUME STAGE-II NONSEMINOMATOUS GERM-CELL TESTIS TUMORS, Urologic clinics of North America, 20(1), 1993, pp. 93-109
ROLE OF PRIMARY CHEMOTHERAPY IN STAGE-I AND LOW-VOLUME STAGE-II NONSEMINOMATOUS GERM-CELL TESTIS TUMORS (CORRECTED VERSION OF LA258)
Authors: STERNBERG CN
Citation: Cn. Sternberg, ROLE OF PRIMARY CHEMOTHERAPY IN STAGE-I AND LOW-VOLUME STAGE-II NONSEMINOMATOUS GERM-CELL TESTIS TUMORS (CORRECTED VERSION OF LA258), Urologic clinics of North America, 20(1), 1993, pp. 93-109
NEOADJUVANT M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN) FOR INFILTRATING TRANSITIONAL-CELL CARCINOMA OF THE BLADDER
Authors: STERNBERG CN ARENA MG CALABRESI F DECARLI P PLATANIA A ZEULI M GIANNARELLI D CANCRINI A PANSADORO V
Citation: Cn. Sternberg et al., NEOADJUVANT M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN) FOR INFILTRATING TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, Cancer, 72(6), 1993, pp. 1975-1982
Risultati: 1-17 |